Management of malignant pleural effusions
- PMID: 15182263
- DOI: 10.1111/j.1440-1843.2004.00566.x
Management of malignant pleural effusions
Abstract
Malignant pleural effusion is a common clinical problem. Evacuation of the pleural fluid and prevention of its reaccumulation are the main aims of management. Pleurodesis should be attempted early, although considerable practice variations exist in the way it is performed. There is a lack of consensus among respiratory physicians worldwide on the optimal method and agent for pleurodesis. Talc remains the most commonly used pleurodesing compound in most countries. While talc produces a higher success rate than other compounds, it generates more side-effects. The association between talc and ARDS continues to be debated. Ambulatory small-bore pleural catheter drainage followed by intrapleural instillation of a pleurodesing agent is increasingly accepted as an alternative to conventional in-patient pleurodesis. Development of novel methods to control pleural fluid formation should be made a high priority in future pleural research.
Similar articles
-
Malignant pleural effusion, current and evolving approaches for its diagnosis and management.Lung Cancer. 2006 Oct;54(1):1-9. doi: 10.1016/j.lungcan.2006.04.016. Epub 2006 Aug 7. Lung Cancer. 2006. PMID: 16893591 Review.
-
Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions.J BUON. 2006 Oct-Dec;11(4):463-7. J BUON. 2006. PMID: 17309178
-
Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.Eur J Cardiothorac Surg. 2006 Dec;30(6):827-32. doi: 10.1016/j.ejcts.2006.10.002. Eur J Cardiothorac Surg. 2006. PMID: 17113008 Clinical Trial.
-
[Treatment of malignant pleural effusion by pleurodesis with talc].Chir Ital. 2000 Sep-Oct;52(5):541-7. Chir Ital. 2000. PMID: 11190547 Italian.
-
Pleurodesis for malignant pleural effusions: current controversies and variations in practices.Curr Opin Pulm Med. 2004 Jul;10(4):305-10. doi: 10.1097/01.mcp.0000129756.87090.55. Curr Opin Pulm Med. 2004. PMID: 15220757 Review.
Cited by
-
[Clinical role of F-18 FDG PET/CT in differentiating malignant and benign pleural effusion in patients with lung cancer].Zhongguo Fei Ai Za Zhi. 2012 Nov;15(11):652-5. doi: 10.3779/j.issn.1009-3419.2012.11.08. Zhongguo Fei Ai Za Zhi. 2012. PMID: 23164351 Free PMC article. Chinese.
-
Asymptomatic malignant pleural effusion: to observe or to manage.J Thorac Dis. 2017 Sep;9(Suppl 10):S1146-S1147. doi: 10.21037/jtd.2017.06.52. J Thorac Dis. 2017. PMID: 29214072 Free PMC article. No abstract available.
-
Bleomycin in the treatment of 50 cases with malignant pleural effusion.Caspian J Intern Med. 2011 Summer;2(3):274-8. Caspian J Intern Med. 2011. PMID: 24049586 Free PMC article.
-
A Multiplexed Cytokeratin Analysis Using Targeted Mass Spectrometry Reveals Specific Profiles in Cancer-Related Pleural Effusions.Neoplasia. 2016 Jul;18(7):399-412. doi: 10.1016/j.neo.2016.06.002. Epub 2016 Jun 25. Neoplasia. 2016. PMID: 27435923 Free PMC article.
-
Management of malignant pleural effusion.Lung. 2013 Apr;191(2):165-75. doi: 10.1007/s00408-012-9445-1. Epub 2013 Jan 13. Lung. 2013. PMID: 23315213 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources